Crossmark Global Holdings’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$738K Buy
4,864
+8
+0.2% +$1.21K 0.01% 723
2025
Q1
$731K Sell
4,856
-73
-1% -$11K 0.01% 716
2024
Q4
$910K Sell
4,929
-66
-1% -$12.2K 0.02% 609
2024
Q3
$984K Sell
4,995
-973
-16% -$192K 0.02% 617
2024
Q2
$1.23M Sell
5,968
-57
-0.9% -$11.8K 0.02% 524
2024
Q1
$1.63M Buy
6,025
+88
+1% +$23.9K 0.03% 477
2023
Q4
$1.4M Hold
5,937
0.03% 504
2023
Q3
$1.16M Sell
5,937
-84
-1% -$16.4K 0.03% 538
2023
Q2
$1.27M Sell
6,021
-42
-0.7% -$8.84K 0.03% 525
2023
Q1
$1.22M Sell
6,063
-63
-1% -$12.7K 0.03% 524
2022
Q4
$1.34M Buy
6,126
+82
+1% +$17.9K 0.03% 495
2022
Q3
$1.19M Sell
6,044
-148
-2% -$29.1K 0.03% 503
2022
Q2
$1.33M Sell
6,192
-260
-4% -$55.6K 0.03% 494
2022
Q1
$1.83M Sell
6,452
-600
-9% -$170K 0.04% 445
2021
Q4
$2.66M Sell
7,052
-4,345
-38% -$1.64M 0.06% 327
2021
Q3
$4.7M Sell
11,397
-7,477
-40% -$3.09M 0.11% 203
2021
Q2
$6.98M Buy
18,874
+228
+1% +$84.3K 0.16% 151
2021
Q1
$5.4M Sell
18,646
-218
-1% -$63.2K 0.13% 173
2020
Q4
$4.71M Buy
18,864
+519
+3% +$130K 0.12% 191
2020
Q3
$4.15M Buy
18,345
+977
+6% +$221K 0.12% 193
2020
Q2
$3.03M Buy
17,368
+1,294
+8% +$226K 0.09% 251
2020
Q1
$2.03M Buy
16,074
+1,028
+7% +$130K 0.07% 283
2019
Q4
$2.3M Buy
15,046
+271
+2% +$41.4K 0.06% 326
2019
Q3
$1.96M Sell
14,775
-474
-3% -$62.8K 0.06% 360
2019
Q2
$2.16M Sell
15,249
-6,896
-31% -$979K 0.06% 360
2019
Q1
$3.22M Buy
22,145
+434
+2% +$63K 0.09% 252
2018
Q4
$2.46M Sell
21,711
-2,133
-9% -$241K 0.08% 295
2018
Q3
$3.21M Sell
23,844
-436
-2% -$58.7K 0.08% 275
2018
Q2
$2.73M Buy
24,280
+70
+0.3% +$7.86K 0.07% 299
2018
Q1
$2.58M Sell
24,210
-1,269
-5% -$135K 0.07% 347
2017
Q4
$2.79M Buy
25,479
+1,730
+7% +$189K 0.07% 341
2017
Q3
$2.57M Buy
+23,749
New +$2.57M 0.07% 349
2016
Q3
$2.57M Buy
+23,749
New +$2.57M 0.07% 349